Clinical breath analysis: Discriminating between human endogenous compounds and exogenous (environmental) chemical confounders

Journal of Breath Research

Volumn 7, Issue 1, 2013, Pages

  Pleil, Joachim D ^a   Stiegel, Matthew A ^b   Risby, Terence H ^c  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVIRONMENTAL CHEMICAL; VOLATILE ORGANIC COMPOUND;

ARTICLE; BREATH ANALYSIS; ELIMINATION REACTION; ENVIRONMENTAL EXPOSURE; EXOGENOUS VARIABLE; HUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; BIOLOGICAL MODEL; EXHALATION; METABOLISM; STATISTICAL MODEL;

BREATH TESTS; ENVIRONMENTAL EXPOSURE; EXHALATION; HUMANS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; VOLATILE ORGANIC COMPOUNDS;

EID: 84874864097     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/7/1/017107     Document Type: Article

References (56)

1. Amann A, Miekisch W, Schubert J, Pleil J and Risby T 2010 Methodological issues of sample collection and analysis of exhaled breath European Respiratory Society Monograph 49 96-114
2. Amann A and Smith D (ed) 2005 Breath Analysis for Diagnosis and Therapeutic Monitoring (Singapore: World Scientific)
3. Basanta M, Jarvis R M, Xu Y, Blackburn G, Tal-Singer R, Woodcock A, Singh D, Goodacre R, Thomas C L and Fowler S J 2010 Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers Analyst 135 315-20
4. Batterman S A, Franzblau A, D'arcy J B, Sargent N E, Gross K B and Schreck R M 1998 Breath, urine, and blood measurements as biological exposure indices of short-term inhalation exposure to methanol Int. Arch. Occup. Environ. Health 71 325-35 (Pubitemid 28408355)
5. Beauchamp J 2011 Inhaled today, not gone tomorrow: pharmacokinetics and environmental exposure of volatiles in exhaled breath J. Breath Res. 5 037103
6. Brugnone F, Perbellini L, Wang G Z, Maranelli G, Raineri E, De Rosa E, Saletti C, Soave C and Romeo L 1993 Blood styrene concentrations in a normal population and in exposed workers 16 hours after the end of the workshift Int. Arch. Occup. Environ. Health 65 125-30 (Pubitemid 23315365)
7. Buszewski B, Kesy M, Ligor T and Amann A 2007 Human exhaled air analytics: biomarkers of diseases Biomed. Chromatogr. 21 553-66 (Pubitemid 46937852)
8. Cao W and Duan Y 2006 Breath analysis: potential for clinical diagnosis and exposure assessment Clin. Chem. 52 800-11 (Pubitemid 43673257)
9. Chiu W A, Micallef S, Monster A C and Bois F Y 2007 Toxicokinetics of inhaled trichloroethylene and tetrachloroethylene in humans at 1 ppm: empirical results and comparisons with previous studies Toxicol. Sci. 95 23-36 (Pubitemid 44942775)
10. Clewell H J III 1995 The application of physiologically based pharmacokinetic modeling in human health risk assessment of hazardous substances Toxicol. Lett. 79 207-17
11. Fens N, Zwinderman A H, Van Der Schee M P, De Nijs S B, Dijkers E, Roldaan A C, Cheung D, Bel E H and Sterk P J 2009 Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma Am. J. Respir. Crit. Care Med. 180 1076-82
12. Fisher J W, Mahle D and Abbas R 1998 A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol Toxicol. Appl. Pharmacol. 152 339-59 (Pubitemid 28492276)
13. Fuchs P, Loeseken C, Schubert J K and Miekisch W 2010 Breath gas aldehydes as biomarkers of lung cancer Int. J. Cancer 126 2663-70
14. Furtaw E J Jr 2001 An overview of human exposure modeling activities at the USEPA's National Exposure Research Laboratory Toxicol. Indust. Health 17 302-14 (Pubitemid 36098378)
15. Gage J C, Lagesson V and Tunek A 1977 A method for the determination of low concentrations of organic vapours in air and exhaled breath Ann. Occup. Hyg. 20 127-34 (Pubitemid 8393086)
16. Jones A W and Andersson L 1996 Variability of the blood/breath alcohol ratio in drinking drivers J. Forensic Sci. 41 916-21 (Pubitemid 26377869)
17. Kim D, Andersen M E, Pleil J D, Nylander-French L A and Prah J D 2007 Refined PBPK model of aggregate exposure to methyl tertiary-butyl ether Toxicol. Lett. 169 222-35 (Pubitemid 46437429)
18. Kischkel S, Miekisch W, Sawacki A, Straker E M, Trefz P, Amann A and Schubert J K 2010 Breath biomarkers for lung cancer detection and assessment of smoking related effects - confounding variables, influence of normalization and statistical algorithms Clin. Chim. Acta 411 1637-44
19. Landon M J, Matson A M, Royston B D, Hewlett A M, White D C and Nunn J F 1993 Components of the inspiratory-arterial isoflurane partial pressure difference Br. J. Anaesthesiol. 70 605-11 (Pubitemid 23169050)
20. Miekisch W, Schubert J K and Noeldge-Schomburg G F 2004 Diagnostic potential of breath analysis - focus on volatile organic compounds Clin. Chim. Acta 347 25-39 (Pubitemid 39099603)
21. Modak A S 2007 Stable isotope breath tests in clinical medicine: a review J. Breath Res. 1 014003
22. Moser B, Bodrogi F, Eibl G, Lechner M, Rieder J and Lirk P 2005 Mass spectrometric profile of exhaled breath - field study by PTR-MS Respir. Physiol. Neurobiol. 145 295-300 (Pubitemid 40215660)
23. Mukhopadhyay R 2004 Don't waste your breath. Researchers are developing breath tests for diagnosing diseases, but how well do they work? Anal. Chem. 76 273A-6A
24. Peng G, Hakim M, Broza Y Y, Billan S, Abdah-Bortnyak R, Kuten A, Tisch U and Haick H 2010 Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors Br. J. Cancer 103 542-51
25. Perbellini L, Brugnone F, Caretta D and Maranelli G 1985 Partition coefficients of some industrial aliphatic hydrocarbons (C5-C7) in blood and human tissues Br. J. Indust. Med. 42 162-7 (Pubitemid 15076873)
26. Perbellini L, Princivalle A, Cerpelloni M, Pasini F and Brugnone F 2003 Comparison of breath, blood and urine concentrations in the biomonitoring of environmental exposure to 1,3-butadiene, 2,5-dimethylfuran, and benzene Int. Arch. Occup. Environ. Health 76 461-6 (Pubitemid 37038173)
27. Pezzagno G and Imbriani M 1995 Factors affecting the biological levels of benzene in humans Adv. Occup. Med. Rehab. 1 27-38
28. Phillips M, Cataneo R N, Cummin A R, Gagliardi A J, Gleeson K, Greenberg J, Maxfield R A and Rom W N 2003 Detection of lung cancer with volatile markers in the breath Chest 6 2115-23 (Pubitemid 36706741)
29. Phillips M, Gleeson K, Hughes J M, Greenberg J, Cataneo R N, Baker L and Mcvay W P 1999 Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study Lancet 353 1930-3 (Pubitemid 29255706)
30. Phillips M, Greenberg J and Awad J 1994 Metabolic and environmental origins of volatile organic compounds in breath J. Clin. Pathol. 47 1052-3
31. Pleil J D 2008 Role of exhaled breath biomarkers in environmental health science J. Toxicol. Environ. Health B: Crit. Rev. 11 613-29
32. Pleil J D 2010 Breath biomarkers networking sessions at PittCon 2010, Orlando, Florida J. Breath Res. 4 029001
33. Pleil J D 2011 Non invasive biomedical analysis. Breath networking session at PittCon 2011, Atlanta, Georgia J. Breath Res. 5 029001
34. Pleil J D, Fisher J W and Lindstrom A B 1998 Trichloroethene levels in human blood and exhaled breath from controlled inhalation exposure Environ. Health Perspect. 106 573-80 (Pubitemid 28495433)
35. Pleil J D, Kim D, Prah J D and Rappaport S M 2007 Exposure reconstruction for reducing uncertainty in risk assessment: example using MTBE biomarkers and a simple pharmacokinetic model Biomarkers 12 331-48 (Pubitemid 46952297)
36. Pleil J D and Lindstrom A B 1997 Exhaled human breath measurement method for assessing exposure to halogenated volatile organic compounds Clin. Chem. 43 723-30 (Pubitemid 27208772)
37. Pleil J D and Lindstrom A B 1998 Sample timing and mathematical considerations for modeling breath elimination of volatile organic compounds Risk Anal. 18 585-602
38. Poli D, Goldoni M, Corradi M, Acampa O, Carbognani P, Internullo E, Casalini A and Mutti A 2010 Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS J. Chromatogr. B 878 2643-51
39. Raymer J H, Pellizzari E D, Thomas K W, Kizakevich P and Cooper S D 1992a Kinetics of low-level volatile organic compounds in breath: relationship between concentrations measured in exposure air and alveolar air J. Exposure Anal. Environ. Epidemiol. 2 67-83
40. Raymer J H, Thomas K W, Pellizzari E D, Cooper S D, Smith D J, Kizakevich P and Pugh D 1992b Breath and blood measurements of individuals exposed to volatile organic compounds: elimination from the third compartment Final Report Contract 68-02-4544
41. Risby T H 2008 Critical issues for breath analysis J. Breath Res. 2 030302
42. Risby T H and Sehnert S S 1999 Clinical application of breath biomarkers of oxidative stress status Free Radical Biol. Med. 27 1182-92 (Pubitemid 30001477)
43. Sato A and Nakajima T 1979 Dose-dependent metabolic interaction between benzene and toluene in vivo and in vitro Toxicol. Appl. Pharmacol. 48 249-56 (Pubitemid 9197371)
44. Shestivska V, Spanel P, Dryahina K, Smith D, Musilek M and Nemec A 2012 Variability in the concentrations of volatile metabolites emitted by genotypically different strains of Pseudomonas aeruginosa J. Appl. Microbiol. 113 701-13
45. Smith A Q, Campbell J L, Keys D A and Fisher J W 2005 Rat tissue and blood partition coefficients for n-alkanes (C8 to C12) Int. J. Toxicol. 24 35-41
46. Spanel P and Smith D 2011 Progress in SIFT-MS:breath analysis and other applications Mass Spectrom. Rev. 30 236-67
47. Tan Y M, Liao K H, Conolly R B, Blount B C, Mason A M and Clewell H J 2006 Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform J. Toxicol. Environ. Health A 69 1727-56 (Pubitemid 44174510)
48. Tardif R, Liu L and Raizenne M 2004 Exhaled ethanol and acetaldehyde in human subjects exposed to low levels of ethanol Inhal. Toxicol. 16 203-7 (Pubitemid 38470383)
49. Ulanowska A, Kowalkowski T, Hrynkiewicz K, Jackowski M and Buszewski B 2011 Determination of volatile organic compounds in human breath for Helicobacter pylori detection by SPME-GC/MS Biomed. Chromatogr. 25 391-7
50. Wallace L, Buckley T, Pellizzari E and Gordon S 1996 Breath measurements as volatile organic biomarkers Environ. Health Perspect. 104 861-9 (Pubitemid 26402323)
51. Wallace L A, Nelson W C, Pellizzari E D and Raymer J H 1997 Uptake and decay of volatile organic compounds at environmental concentrations: application of a four-compartment model to a chamber study of five human subjects J. Exposure Anal. Environ. Epidemiol. 7 141-63 (Pubitemid 27270382)
52. Wallace L A and Pellizzari E D 1995 Recent advances in measuring exhaled breath and estimating exposure and body burden for volatile organic compounds (VOCs) Environ. Health Perspect. 103 95-8
53. Wallace L A, Pellizzari E D and Gordon S 1993 A linear model relating breath concentrations to environmental exposures: application to a chamber study of four volunteers exposed to volatile organic chemicals J. Exposure Anal. Environ. Epidemiol. 3 75-102 (Pubitemid 23237802)
54. Xu X and Weisel C P 2005 Human respiratory uptake of chloroform and haloketones during showering J. Exposure Anal. Environ. Epidemiol. 15 6-16 (Pubitemid 40170979)
55. Yasuda N, Lockhart S H, Eger E I II, Weiskopf R B, Johnson B H, Freire B A and Fassoulaki A 1991a Kinetics of desflurane, isoflurane, and halothane in humans Anesthesiology 74 489-98
56. Yasuda N, Lockhart S H, Eger E I II, Weiskopf R B, Liu J, Laster M, Taheri S and Peterson N A 1991b Comparison of kinetics of sevoflurane and isoflurane in humans Anesth. Analg. 72 316-24